Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PMI Biopharma Solutions and Nashville Biosciences Form Alliance | Contract Pharma
Breaking News, Collaborations & Alliances

PMI Biopharma Solutions and Nashville Biosciences Form Alliance

To combine drug discovery support with next-gen sequencing

PMI Biopharma Solutions, a provider of research, pharmaceutical development, and early-phase clinical manufacturing services and Nashville Biosciences, a clinical-genomic and bioinformatics company, have formed a drug discovery and development collaboration.
 
Under this alliance, both organizations will have the opportunity to bundle Nashville Bioscience’s data and in silico technology with PMI’s comprehensive laboratory services and scientific expertise to experimentally test mechanistic and therapeutic hypotheses for a comprehensive drug target identification and validation package.
 
“With both organizations located in Nashville it was an easy decision to pair our capabilities to better serve our clients,” said David Sunseri, chief executive officer, PMI Biopharma Solutions. “This alliance will allow clients a smooth transition from in silico to in vitro studies.”
 
Leeland Ekstrom, chief operating officer and founder of Nashville Biosciences, said, “Our respective capabilities fit together very nicely to advance our clients’ research & development in the life sciences. We are excited to collaborate with PMI Biopharma Solutions to better serve our clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters